Cargando…
Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920202/ https://www.ncbi.nlm.nih.gov/pubmed/34010099 http://dx.doi.org/10.1080/21645515.2021.1894898 |
| _version_ | 1784669075598737408 |
|---|---|
| author | Gómez, Jorge A. Pinto, Thatiana de Jesus Pereira Guevara, Javier Nieto de Noronha, Tatiana Guimarães |
| author_facet | Gómez, Jorge A. Pinto, Thatiana de Jesus Pereira Guevara, Javier Nieto de Noronha, Tatiana Guimarães |
| author_sort | Gómez, Jorge A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8920202 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Taylor & Francis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89202022022-03-15 Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” Gómez, Jorge A. Pinto, Thatiana de Jesus Pereira Guevara, Javier Nieto de Noronha, Tatiana Guimarães Hum Vaccin Immunother Pneumococcal – Letters Taylor & Francis 2021-05-19 /pmc/articles/PMC8920202/ /pubmed/34010099 http://dx.doi.org/10.1080/21645515.2021.1894898 Text en © 2021 GlaxoSmithKline. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
| spellingShingle | Pneumococcal – Letters Gómez, Jorge A. Pinto, Thatiana de Jesus Pereira Guevara, Javier Nieto de Noronha, Tatiana Guimarães Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_full | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_fullStr | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_full_unstemmed | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_short | Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants” |
| title_sort | response to article by johnna perdrizet et al.,“cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (pcv10) with the 13-valent pneumococcal conjugate vaccine (pcv13) in brazil infants” |
| topic | Pneumococcal – Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920202/ https://www.ncbi.nlm.nih.gov/pubmed/34010099 http://dx.doi.org/10.1080/21645515.2021.1894898 |
| work_keys_str_mv | AT gomezjorgea responsetoarticlebyjohnnaperdrizetetalcosteffectivenessanalysisofreplacingthe10valentpneumococcalconjugatevaccinepcv10withthe13valentpneumococcalconjugatevaccinepcv13inbrazilinfants AT pintothatianadejesuspereira responsetoarticlebyjohnnaperdrizetetalcosteffectivenessanalysisofreplacingthe10valentpneumococcalconjugatevaccinepcv10withthe13valentpneumococcalconjugatevaccinepcv13inbrazilinfants AT guevarajaviernieto responsetoarticlebyjohnnaperdrizetetalcosteffectivenessanalysisofreplacingthe10valentpneumococcalconjugatevaccinepcv10withthe13valentpneumococcalconjugatevaccinepcv13inbrazilinfants AT denoronhatatianaguimaraes responsetoarticlebyjohnnaperdrizetetalcosteffectivenessanalysisofreplacingthe10valentpneumococcalconjugatevaccinepcv10withthe13valentpneumococcalconjugatevaccinepcv13inbrazilinfants |